ERM partner Roni Abelski has featured in 2016 Mergers & Acquisitions Annual Review by Financier Worldwide, a publication that canvasses the opinions of leading experts from around the world who advise on mergers & acquisitions (M&A). Roni contributed the Israel chapter of the report, providing insight into key developments in the region.
Among the areas that Roni addressed were the M&A activity in Israel over the past year, the steps a buyer should take to minimise transactional risk in a deal, the importance of local market knowledge when it comes to closing deals and recent regulations that will affect transactions in Israel.
On the M&A activity in Israel, Roni commented: “The M&A market in Israel has seen a great deal of activity in the last 12-18 months. A large portion of M&A transactions are focused on the high-tech sector where Israel has shown a strong record for innovation that is internationally recognised. This has led to an increasing number of global corporations, most of which have not traditionally been focused on investing in the development of technology, open innovation hubs within Israel to give their industries a technological push. This, combined with acquisitions in non-tech focused industries, means that the Israeli M&A landscape has been very broad. In terms of industries of focus, high-tech companies continue to dominate, especially in cyber and FinTech, where Israel is commonly regarded as a leading source of disruptive technology. Agro-tech and medical devices continue to show growth and account for a significant source of international acquisitions of Israeli companies.”
For a full copy of the report, please click here.
Corporate and M&A practice
Epstein Rosenblum Maoz (ERM)’s corporate practice is widely renowned for its cross-border M&A expertise and it regularly advises leading Israeli and international clients on the most complex transactions carried out in Israel or by Israeli companies abroad. Please click here to read more about our corporate and M&A practice.
For further information, please contact Roni Abelski or another member of our team.